Infectious Diseases News and Research

RSS

Rib-X Pharmaceuticals to present delafloxacin Phase 2 study data at 20th ECCMID

Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that an oral presentation of data for delafloxacin, its lead antibiotic candidate, will be given at the 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 10-14, in Vienna, Austria by Paul G. Ambrose, Pharm.D, FIDSA, Director, Institute for Clinical Pharmacodynamics, Ordway Research Institute.

12 Apr 2010

Clinical and preclinical malaria vaccine data presented at Keystone Symposium

GenVec, Inc. announced that encouraging clinical and preclinical malaria vaccine data were presented at the Keystone Symposium -- Malaria: New Approaches to Understanding Host-Parasite Interactions taking place April 11-16, 2010 in Copper Mountain, Colorado.

12 Apr 2010

Scientists identify specific mechanism that triggers resistance to vancomycin

A new study led by the scientific director of the Michael G. DeGroote Institute for Infectious Disease Research has uncovered for the first time how bacteria recognize and develop resistance to a powerful antibiotic used to treat superbug infections.

12 Apr 2010

Optimer Pharmaceuticals announces results from second Phase 3 clinical study of fidaxomicin

Optimer Pharmaceuticals, Inc. announced that the top-line results from its second fidaxomicin Phase 3 clinical study in patients with Clostridium difficile infection were presented today at the 20th Annual European Congress of Clinical Microbiology and Infectious Diseases in Vienna, Austria.

12 Apr 2010

Remediable conditions influence health, development and growth of young children

Pediatric researchers from Boston Medical Center, in partnership with other Children's HealthWatch investigators in Minneapolis, Little Rock, Philadelphia, and Baltimore, have found that the cumulative effects of crowded and unstable housing and uncertain supplies of food and heat act together to decrease the chances of normal growth and development and good physical health among infants and toddlers.

12 Apr 2010

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

Cempra Pharmaceuticals today announced poster presentations on its novel antibiotic CEM-101, a next-generation macrolide, and CEM-102, the company's proprietary front-loading oral dosing regimen of sodium fusidate, at the 20th European Congress of Clinical Microbiology and Infectious Disease, April 10 to 13, 2010, in Vienna Austria.

12 Apr 2010

WHO Director-General turns attention to conditions in slums to mark World Health Day

WHO Director-General Margaret Chan said addressing living conditions in the world's slums is important to improving urban health - the focus of World Health Day on Wednesday, Agence France-Presse reports.

9 Apr 2010

AmericanEHR Partners Program introduced to help medical practitioners compare EHR systems

A collaboration developing a new Web site to help medical practitioners compare electronic health records systems was announced today by its founding partners, the American College of Physicians and Cientis Technologies.

9 Apr 2010

Immune system mouse models help study biology of T cells and their role in toxoplasmosis

Using T cells primed for the infectious disease toxoplasmosis, Whitehead Institute researchers have created novel mouse models of the immune system that more accurately reflect how immune cells actually respond to pathogens in their presence.

9 Apr 2010

World Health Day: Addressing health and quality of life for city dwellers

This year's World Health Day theme, "Urbanization and Health: Urban Health Matters," reminds us that many of those people most at risk of poor health around the world live in cities.

8 Apr 2010

USAID: World Health Day 2010 focuses on world's growing urban population

This year the focus of World Health Day is on the world's growing urban population. The theme, "1000 cities, 1000 lives" provides an opportunity to highlight the work that is being done to improve health in urban settings. The unprecedented rate of urban growth has far outstripped the ability of these cities to provide infrastructure for new residents.

8 Apr 2010

Enrollment completes for Inovio Biomedical's dose escalation phase I trial of cervical cancer vaccine

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that the company has completed enrollment of all subjects for its therapeutic cervical cancer vaccine (VGX-3100) phase I trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18, and is delivered via in vivo electroporation.

8 Apr 2010

Cempra Pharmaceuticals announces schedule of poster presentations at ECCMID 2010

Cempra Pharmaceuticals today announced its schedule of poster presentations at the 20th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) in Vienna, Austria, on April 10-13, 2010.

8 Apr 2010

Debiopharm Group, Biocartis sign investment agreement

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of innovative prescription drugs that target unmet medical needs, and which has embarked in the field of companion diagnostics with a view to progressing in the area of personalized medicine, today announced the signature of an investment agreement with Biocartis.

8 Apr 2010

Cities, leaders worldwide mark World Health Day

Cities throughout the world are marking World Health Day today by promoting urban health, as part of the WHO's "1,000 cities, 1,000 lives" campaign, CNN reports (Shaikh, 4/7).

8 Apr 2010

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

Cepheid will initiate European launch of its newest addition to the GeneXpert® family of molecular diagnostic testing systems, the GeneXpert Infinity-48, at the 20th annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Vienna, Austria. The GeneXpert Infinity-48 System is the world's first and only fully-automated, random-access system designed for management of the entire molecular testing workflow — from sample data, cartridge loading and unloading, to final reporting of test results and disposal of cartridges.

7 Apr 2010

WHO launches campaign to highlight urban planning to improve public health

Urban settings have a direct impact on the health of the people who live there. On World Health Day WHO is launching a campaign to highlight urban planning as a crucial link to building a healthy 21st century. In particular, the Organization calls upon municipal authorities, concerned residents, advocates for healthy living and others to take a close look at health inequities in cities and take action.

7 Apr 2010

Jantibody Therapeutics, Pfenex collaborate in production of HSP-avidin fusion proteins

Boston BioCom LLC today announced the successful completion of a collaborative research agreement between its Jantibody Therapeutics LLC subsidiary and Pfenex Inc., resulting in the rapid production of a HSP-avidin fusion protein for the Jantibodies self-assembling vaccines platform.

7 Apr 2010

Media outlets examine urbanization, health ahead of World Health Day

Several media outlets examine the health risks associated with rapid urbanization around the world - the theme of this year's World Health Day, to be marked on Wednesday.

7 Apr 2010

Optimer Pharmaceuticals to present data from fidaxomicin Phase 3 studies at 20th ECCMID

Optimer Pharmaceuticals, Inc. announced that data from the fidaxomicin Phase 3 clinical studies will be presented at the 20th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Vienna, Austria.

7 Apr 2010

Infectious Diseases News and Research

Rib-X Pharmaceuticals to present delafloxacin Phase 2 study data at 20th ECCMID

Clinical and preclinical malaria vaccine data presented at Keystone Symposium

Scientists identify specific mechanism that triggers resistance to vancomycin

Optimer Pharmaceuticals announces results from second Phase 3 clinical study of fidaxomicin

Remediable conditions influence health, development and growth of young children

Cempra to make poster presentations on CEM-101 and CEM-102 at ECCMID 2010

WHO Director-General turns attention to conditions in slums to mark World Health Day

AmericanEHR Partners Program introduced to help medical practitioners compare EHR systems

Immune system mouse models help study biology of T cells and their role in toxoplasmosis

World Health Day: Addressing health and quality of life for city dwellers

USAID: World Health Day 2010 focuses on world's growing urban population

Enrollment completes for Inovio Biomedical's dose escalation phase I trial of cervical cancer vaccine

Cempra Pharmaceuticals announces schedule of poster presentations at ECCMID 2010

Debiopharm Group, Biocartis sign investment agreement

Cities, leaders worldwide mark World Health Day

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

WHO launches campaign to highlight urban planning to improve public health

Jantibody Therapeutics, Pfenex collaborate in production of HSP-avidin fusion proteins

Media outlets examine urbanization, health ahead of World Health Day

Optimer Pharmaceuticals to present data from fidaxomicin Phase 3 studies at 20th ECCMID

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News